Answers are grounded in this paper and cite their sources.
Current evidence suggests that while trypanocidal therapy reduces parasite detection, it does not prevent the progression of advanced Chagas cardiomyopathy, highlighting the need for early treatment and new therapeutic strategies.
Global Heart is the official and primary publication of the World Heart Federation, offering a platform for the dissemination of knowledge on research, developments, trends, solutions and public health programmes in the area of cardiovascular disease. Global Heart welcomes research results, points of view and educational material on the prevention, treatment and control of cardiovascular disease with a special focus on low and middle-income countries which are facing the brunt of epidemiological transition.Global Heart strongly encourages authors to adhere to CONSORT, STROBE, STARD, and PRISMA guidelines for reporting of clinical trials, observational studies, diagnostic test accuracy papers, and systematic reviews or meta-analyses. Authors are required for submission to download and complete the appropriate Equator Network checklist: http://www.equator-network.org/.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2015) conducted an editorial in Chagas disease. Trypanocidal therapy was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: